Miran Kim
Affiliations: | Brown University, Providence, RI |
Area:
Molecular Biology, Cell Biology, GeneticsGoogle:
"Miran Kim"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim M, Hui KM, Shi M, et al. (2022) Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. Hepatology Communications |
| Tomimaru Y, Aihara A, Wands JR, et al. (2019) A Novel Drug, CC-122, Inhibits Tumor Growth in Hepatocellular Carcinoma through Downregulation of an Oncogenic TCF-4 Isoform. Translational Oncology. 12: 1345-1356 |
| Iwagami Y, Casulli S, Nagaoka K, et al. (2017) Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma. Heliyon. 3: e00407 |
| Iwagami Y, Huang CK, Olsen MJ, et al. (2015) Aspartate β-hydroxylase modulates cellular senescence via glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology (Baltimore, Md.) |
| Chung W, Kim M, de la Monte S, et al. (2015) Activation of signal transduction pathways during hepatic oncogenesis. Cancer Letters |
| Xu CQ, de la Monte SM, Tong M, et al. (2015) Chronic Ethanol-Induced Impairment of Wnt/β-Catenin Signaling is Attenuated by PPAR-δ Agonist. Alcoholism, Clinical and Experimental Research. 39: 969-979 |
| Huang CK, Yu T, de la Monte SM, et al. (2015) Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model. Journal of Hepatology. 63: 191-8 |
| Wands JR, Kim M. (2014) WNT/β-catenin signaling and hepatocellular carcinoma. Hepatology (Baltimore, Md.). 60: 452-4 |
| Koga H, Kim M, Nakamura A, et al. (2014) Abstract 330: The Wnt signal transcription factor TCF-4 directly regulates Bcl-xL expression in human hepatocellular carcinoma cells Cancer Research. 74: 330-330 |
| Pez F, Lopez A, Kim M, et al. (2013) Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. Journal of Hepatology. 59: 1107-17 |